Disulfiram (Antabuse) and Blood Sugar: Indirect Effects, Nutritional Risks, and Dangerous Reactions

Disulfiram (Antabuse®) does not directly alter glucose metabolism. However, its clinical use context creates indirect metabolic considerations.

Potential Indirect Effects on Glycemia

• Alcohol-Avoidance Behavior: Successful abstinence may improve nutritional status and glycemic control in patients with alcohol use disorder (AUD) and comorbid diabetes.
• Disulfiram-Ethanol Reaction (DER): If alcohol consumed → acetaldehyde accumulation → severe nausea/vomiting → transient starvation ketosis, hypoglycemia risk (especially on insulin/sulfonylureas).
• Appetite Suppression: Nausea from DER or drug itself → reduced intake → glycemic variability.

Nutritional Deficiencies

• Thiamine (B1): AUD + disulfiram ↑ risk of Wernicke-Korsakoff syndrome (ophthalmoplegia, ataxia, confabulation). Prophylactic thiamine 100 mg/day recommended.
• Pyridoxine (B6): Disulfiram may interfere with metabolism; supplementation sometimes used.

Dangerous Adverse Effects

• Severe DER: Hypotension, arrhythmia, MI, respiratory depression, seizures, death. Absolute alcohol avoidance required.
• Hepatotoxicity: Elevated LFTs, hepatitis, rare fulminant failure. Monitor LFTs baseline, q1–2 mo × 3, then periodically.
• Neurotoxicity: Peripheral neuropathy (dose/duration-related), optic neuritis, encephalopathy, psychosis.
• Psychiatric: Depression, suicidality, mania.
• Dermatologic: Acneiform eruption, allergic dermatitis.

Monitoring Recommendations

• LFTs, CBC, neuropathy screen, mental status at follow-ups.
• Counsel on hidden alcohol (sauces, mouthwash, cold meds).
• MedicAlert bracelet recommended.

Disulfiram is a deterrent, not a cure. Best outcomes with comprehensive AUD treatment (counseling, support groups, naltrexone/acamprosate).